-
Analyst On Endologix: No Sense In Downgrading Now
Thursday, May 18, 2017 - 10:45am | 593Endologix, Inc. (NASDAQ: ELGX) announced on Thursday after the market close that it needs to conduct a confirmatory clinical trial for its Nellix Endovascular Aneurysm Sealing System with the previously updated instructions for use and the Gen2 device design. This follows the company's meeting...
-
Promising Zika Research Fuels Cerus Stock Surge
Thursday, January 28, 2016 - 4:54pm | 468Shares of Cerus Corporation (NASDAQ: CERS) were trading up 4.2 percent Thursday as news of research that successfully inactivated the Zika virus in human blood circulated among traders. BTIG analysts Karen Koski, Dr. Sean Lavin and Andrea Alfonso reiterated their "buy" rating for...